Edition:
India

Akebia Therapeutics Inc (AKBA.OQ)

AKBA.OQ on NASDAQ Stock Exchange Global Market

10.29USD
20 Jul 2018
Change (% chg)

-- (--)
Prev Close
$10.29
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
185,102
52-wk High
$20.25
52-wk Low
$7.90

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Mar '18 45.93 -0.482
FY 2017 Dec '17 87.32 0.259
Sep '17 41.28 -0.493
Jun '17 28.52 -0.527
Mar '17 20.86 -1.149
FY 2016 Dec '16 1.53 -0.989
Sep '16 0.00 -0.958
Jun '16 0.00 -0.946
Mar '16 0.00 -0.700
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Sep-18 7 52.02 65.00 40.00 28.00
Quarter Ending Dec-18 7 67.88 90.00 45.46 38.00
Year Ending Dec-18 7 215.57 240.93 182.79 135.33
Year Ending Dec-19 7 300.36 490.50 170.00 165.67
Earnings (per share)
Quarter Ending Sep-18 6 -0.46 -0.25 -0.62 -0.50
Quarter Ending Dec-18 6 -0.26 0.22 -0.60 -0.27
Year Ending Dec-18 6 -1.60 -1.11 -2.24 -2.77
Year Ending Dec-19 7 -1.30 0.21 -5.07 -0.68
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

Dividends

Growth Rates

Financial Strength

Profitability Ratios

Efficiency

Management Effectiveness

  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -56.90 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Akebia Therapeutics Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 73.83%
# of Holders: 202
Total Shares Held: 41,996,854
3 Mo. Net Change: -140,971
# New Positions: 2
# Closed Positions: 3
# Increased Positions: 8
# Reduced Positions: 9
# Net Buyers: -1
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.